# Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone

> **NCT02733679** · PHASE4 · COMPLETED · sponsor: **NHS Tayside** · enrollment: 27 (actual)

## Conditions studied

- Ataxia-Telangiectasia

## Interventions

- **DRUG:** Metformin
- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT02733679
- **Lead sponsor:** NHS Tayside
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-29
- **Primary completion:** 2017-08-30
- **Final completion:** 2017-08-30
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2017-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02733679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02733679, "Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02733679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*